SLC5A2 and chronic kidney disease: For instance, the anti-diabetic sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown unexpected benefits in treating heart failure (11) and that statins, originally used for hyperlipidemia, exhibit anti-inflammatory and antifibrotic effects in conditions such as chronic kidney disease (12).